D
Tharimmune, Inc. THAR
$4.28 -$0.07-1.61% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$4.35
Volume
432,859
Avg Vol (90D)
1,315,672
Market Cap
$171.95M
Dividend & Yield
--
52-Week Range
$0.95 - $9.08
P/E (TTM)
--
EPS (TTM)
-$4.11
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Tharimmune (THAR, $4.27) entered Downtrend as Momentum indicator drops below 0 level on Feb 12, 2026
2/13/2026 - Tickeron - Stocks
Tharimmune (THAR, $4.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 11, 2026
2/12/2026 - Tickeron - Stocks
Tharimmune names Mark Wendland board chair, appoints Angela Radkowski as COO
2/6/2026 - Seeking Alpha - Healthcare
Tharimmune names Mark Wendland board chair, appoints Angela Radkowski as COO
2/6/2026 - SeekingAlpha.com: All News
Tharimmune appoints Angela Radkowski as COO
2/6/2026 - The Fly
Tharimmune appoints Angela Radkowski as COO
2/6/2026 - The Fly
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
2/6/2026 - PR Newswire
Tharimmune Adds New Directors to Support Digital Strategy
2/2/2026 - TipRanks Financial Blog
Tharimmune Elects Jill Sommers and William Wiley to Board of Directors
2/2/2026 - PR Newswire
Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost
1/31/2026 - MarketBeat
Crypto market sheds $150B as Bitcoin drops to $81K and long liquidations top $1.7B
1/30/2026 - Invezz News
Tharimmune (THAR, $3.23) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 26, 2026
1/27/2026 - Tickeron - Stocks
Tharimmune (THAR) Gains Approval to Operate as Super Validator on Canton Network
1/26/2026 - GuruFocus
Tharimmune Announces Expanded Role as Super Validator on Canton Network
1/26/2026 - GuruFocus
Tharimmune approved as Super Validator on Canton Network
1/26/2026 - The Fly
Tharimmune Announces Expanded Role as Super Validator on Canton Network
1/26/2026 - PR Newswire
Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization
1/23/2026 - SeekingAlpha
Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization
1/23/2026 - Seeking Alpha - Long Ideas
Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization
1/23/2026 - SeekingAlpha.com: Most Popular Articles
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
1/22/2026 - GuruFocus
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
1/22/2026 - PR Newswire
Essex LLC Buys 10,155 Shares of Tharimmune Inc (THAR)
1/20/2026 - GuruFocus
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
1/20/2026 - GuruFocus
Tharimmune prices $55M registered offering
1/20/2026 - Seeking Alpha - Healthcare
Tharimmune announces pricing of $55M registered offering
1/20/2026 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$10.34M
Net Income (TTM)
-$10.32M
Balance Sheet
Total Assets (Q)
$7.70M
Total Debt (Q)
$195.50K
Total Liabilities (Q)
$1.54M
Book Value Per Share (Q)
$0.854
Cash Flow
Cash from Operations (TTM)
-$8.72M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$11.56M
Net Change in Cash (TTM)
$2.84M
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
0.98
7-Day Total Return
-20.30%
30-Day Total Return
43.14%
60-Day Total Return
47.08%
90-Day Total Return
47.08%
Year to Date Total Return
26.63%
1-Year Total Return
126.46%
2-Year Total Return
-25.89%
3-Year Total Return
-99.40%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $0.95
52-week High
Aug 25, 2025 - $9.08
Valuation
Market Cap
$171.95M - Micro Cap
Enterprise Value
$164.54M
Price/Sales (TTM)
--
Price/Book (Q)
5.09
Dividends and Shares
Shares Outstanding
6.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tharimmune.com
Phone Number
732 889 3111
Address
34 Shrewsbury Avenue
Red Bank, NJ 07701
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in... more
NASDAQ 02/12/2026 4:00PM Eastern Quotes delayed